https://www.lavfund.com/blog/tp-therapeutics-closes-45m-series-c-financing
SAN DIEGO--(BUSINESS WIRE)--TP Therapeutics, Inc., a clinical-stage biopharmaceutical company focusing on addressing oncology drug resistance, announced today...
series c financingtptherapeuticscloses
https://www.prnewswire.com/news-releases/armo-biosciences-raises-50-million-series-c-financing-300217578.html
/PRNewswire/ -- ARMO BioSciences, Inc., a clinical-stage biotechnology company, today announced the successful completion of a $50 million Series C private...
series c financingarmo biosciencesraisesmillion
https://www.prnewswire.com/news-releases/xlumena-closes-series-c-financing-focuses-on-expanding-global-commercial-presence-and-obtaining-fda-clearance-234204991.html
/PRNewswire/ -- Xlumena, Inc., a leader in the development of advanced endoscopic devices, today announced the close of a $25 million Series C financing. Led...
series c financingclosesexpandingglobalcommercial